3934-87-0Relevant articles and documents
Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture
Zouhiri, Fatima,Mouscadet, Jean-Fran?ois,Mekouar, Khalid,Desma?le, Didier,Savouré, Delphine,Leh, Hervé,Subra, Frédéric,Le Bret, Marc,Auclair, Christian,D'Angelo, Jean
, p. 1533 - 1540 (2000)
Our prior studies showed that polyhydroxylated styrylquinolines are potent HIV-1 integrase (IN) inhibitors that block the replication of HIV-1 in cell culture at nontoxic concentrations. To explore the mechanism of action of these inhibitors, various novel styrylquinoline derivatives were synthesized and tested against HIV-1 IN and in cell-based assays. Regarding the in vitro experiments, the structural requirements for biological activity are a carboxyl group at C-7, a hydroxyl group at C-8 in the quinoline subunit, and an ancillary phenyl ring. However the in vitro inhibitory profile tolerates deep alterations of this ring, e.g. by the introduction of various substituents or its replacement by heteroatomic nuclei. Regarding the ex vivo assays, the structural requirements for activity are more stringent than for in vitro inhibition. Thus, in addition to an o-hydroxy acid group in the quinoline, the presence of one ortho pair of substituents at C-3' and C- 4', particularly two hydroxyl groups, in the ancillary phenyl ring is imperatively required for inhibitory potency. Starting from literature data and the SARs developed in this work, a putative binding mode of styrylquinoline inhibitors to HIV-1 IN was derived.
An efficient stereoselective total synthesis of (±)-trans-dihydronarciclasine
Varró, Gábor,Heged?s, László,Simon, András,Kádas, István
, p. 1544 - 1546 (2016)
A short and efficient stereoselective total synthesis of (±)-trans-dihydronarciclasine (1), a highly potent naturally occurring antineoplastic agent, was developed from readily available vanillin (7). The key intermediate of this new synthesis was a butenone derivative (11), from which the target molecule could be obtained in 14, mostly stereoselective, reaction steps. Our total synthesis has provided an easy and, up to now, the least expensive access to the title alkaloid.
Identification of an extracellular bacterial flavoenzyme that can prevent re-polymerisation of lignin fragments
Rahmanpour, Rahman,King, Lloyd D.W.,Bugg, Timothy D.H.
, p. 57 - 61 (2017)
A significant problem in the oxidative breakdown of lignin is the tendency of phenolic radical fragments to re-polymerise to form higher molecular weight species. In this paper we identify an extracellular flavin-dependent dehydrolipoamide dehydrogenase from Thermobifida fusca that prevents oxidative dimerization of a dimeric lignin model compound, which could be used as an accessory enzyme for lignin depolymerisation.
Design, synthesis and biochemical evaluation of novel 2-amino-3-(7-methoxybenzo[d][1,3]dioxol-5-yl)propanoic acid using Horseradish peroxidase (HRP) activity, cellular ROS inhibition and molecular docking study
Demonceau, Albert,Etsè, Koffi Sénam,Mouithys-Mickalad, Ange,Serteyn, Didier,Zaragoza, Guillermo
, (2021/10/29)
In this paper, we report the design, synthesis and biochemical evaluation of 2-amino-3-(7-methoxybenzo[d][1,3]dioxol-5-yl)propanoic acid 9, a myristicin derivative, from cheap and available vanillin as starting material. Compound 9 is identified as a potential precursor of natural brasiliamide derivatives. All the products are fully characterized. The crystal structure of the intermediate diethyl 2-acetamido-2-((7-methoxybenzo[d][1,3]dioxol-5-yl)methyl)malonate 16, a precursor of this amino acid, is obtained and presented. The interactions stabilizing the crystal packing of 16 were deeply analyzed by considering first the supramolecular stacking and finally, by analyzing the contacts descriptors on the Hirshfeld surface, the molecular fingerprint and the intermolecular energy. Different biochemical properties of the desired amino acid 9 and its selected precursors are investigated. In DPPH test, 9 showed the best anti-radical activity (IC50 = 80.91 μM). The enzymatic, HRP-H2O2/L012, chemiluminescence assay reveals excellent inhibitory effect on the peroxidase activity and a good antioxidant activity of all the tested compounds with the best activity for 9 (IC50 = 0.36 μM). The anti-peroxidase activity observed for compound 9 was confirmed by molecular docking exploration that allows to identify interactions in the HRP-9 complex. Docking results showed that 9 interacts with catalytic and active site residues, especially with Arg38, His42, Ser73, Phe68 and Pro139. Moreover, the inhibition of ROS production by activated HL-60 cells was moderately obtained with compounds 9 and 13. The MTS cell viability test reveals that all tested compounds, except myristicin aldehyde 13, were not cytotoxic indicating that the observed inhibition of ROS production of activated HL-60 cells was not due to cells death. Finally, physicochemical and ADME-Tox predictions suggested that compound 9 could be considered as promising drug candidate.
First synthesis of tabamides A–C and their derivatives: In vitro nitric oxide inhibitory activity
Damodar, Kongara,Jeon, Sung Ho,Lee, Jeong Tae,Shin, Sooyong
supporting information, (2021/11/10)
The first synthesis of natural phenolic amides, tabamides A–C (1–3), and their derivatives (4–12) was accomplished using Stobbe condensation and amide coupling reactions as key steps. The in vitro nitric oxide (NO) inhibitory effects of these compounds in LPS-induced RAW-264.7 macrophages were evaluated as an indicator of anti-inflammatory activity. All compounds tested had a concentration-dependent inhibitory effect on NO production by RAW-264.7 macrophages without significant cytotoxicity. Compound 6, a tabamide A derivative (IC50 = 82.6 μM), followed by tabamide A (1, IC50 = 100.7 μM), was the most potent from the series. The present study revealed that tabamide A (1) could be considered as a lead structure to develop NO production-targeted anti-inflammatory agents.
An Acid-Catalyzed Epoxide Ring-Opening/Transesterification Cascade Cyclization to Diastereoselective Syntheses of (±)-β-Noscapine and (±)-β-Hydrastine
Li, Jihui,Liu, Yongxiang,Song, Xinjing,Wu, Tianxiao,Meng, Jiaxin,Zheng, Yang,Qin, Qiaohua,Zhao, Dongmei,Cheng, Maosheng
supporting information, p. 7149 - 7153 (2019/09/30)
An acid-catalyzed stereoselective epoxide ring-opening/intramolecular transesterification cascade cyclization reaction and N-Boc deprotection was found to be a successful strategy to construct the phthalide tetrahydroisoquinoline skeleton in one pot. Based on this strategy, the unified and highly diastereoselective routes for the total syntheses of (±)-β-Noscapine and (±)-β-Hydrastine were exploited.
Highly Stereoselective Synthesis of trans -Dihydronarciclasine Analogues
Varró, Gábor,Mattyasovszky, Lenke,Grün, Alajos,Simon, András,Hegedüs, László,Kádas, István
, p. 625 - 643 (2017/11/27)
Several new trans -dihydronarciclasine analogues were stereo selectively synthesised by applying our feasible and efficient process developed recently. These new phenanthridone alkaloid derivatives were obtained in both racemic and optically active forms. During their enantioselective syntheses, high selectivities (up to 99% ee) were achieved by using (8 S,9 S)-9-amino(9-deoxy)epiquinine as an organocatalyst. The modifications, the introduction of ethoxy or methoxy groups, were made in ring A of the phenanthridone scaffold.
Synthesis and Pharmacological Evaluation of Noscapine-Inspired 5-Substituted Tetrahydroisoquinolines as Cytotoxic Agents
Devine, Shane M.,Yong, Cassandra,Amenuvegbe, Dzifa,Aurelio, Luigi,Muthiah, Divya,Pouton, Colin,Callaghan, Richard,Capuano, Ben,Scammells, Peter J.
supporting information, p. 8444 - 8456 (2018/09/25)
A series of 5-substituted tetrahydroisoquinolines was synthesized via a 10-step linear synthesis to assess whether replacement of noscapine's southern isobenzofuranone with other moieties resulted in retained cytotoxic activity. One such molecule, 18g, bearing a para-methoxybenzyl functionality with N-ethylcarbamoyl substitution, produced cell-cycle arrest at the G2/M phase with an EC50 of 2.7 μM in the MCF-7 breast-cancer cell line, a 7-fold increase compared with that of noscapine (5). This molecule had similar activity (EC50 of 2.5 μM) against the resistant NCI/AdrRES cell line, demonstrating its potential to overcome or avert known resistance mechanisms, unlike current cytotoxic agents. Compound 18g was found to modify the drug-efflux activity of P-gp and, in combination studies, potentiate the antiproliferative activity of vinblastine. These results provide insights into structural modifications to noscapine that will guide future development toward more potent cytotoxic agents that are active against resistant cancer cells.
The First Enantioselective Total Synthesis of (-)-Trans-Dihydronarciclasine
Varró, Gábor,Hegedus, László,Simon, András,Balogh, Attila,Grün, Alajos,Leveles, Ibolya,Vértessy, Beáta G.,Kádas, István
, p. 1909 - 1917 (2017/06/28)
A feasible and enantioselective total synthesis of (-)-Trans-dihydronarciclasine [(-)-1], a highly biologically active alkaloid, was devised starting from vanillin (8). The key step of this new synthesis was an asymmetric, organocatalytic Michael addition, in which an optically active nitropentanone [(-)-13] was obtained from a butenone derivative (12). Excellent enantioselectivity (>99% ee) was achieved using the (8S,9S)-9-Amino(9-deoxy)epiquinine (16) organocatalyst. The target molecule can be prepared in 13 steps from compound (-)-13. The total synthesis has provided a facile and first access to the ent-form of naturally occurring (+)-Trans-dihydronarciclasine, a highly potent cytostatic alkaloid.
Methoxy group substitution on catechol ring of dopamine facilitates its polymerization and formation of surface coatings
Zhang, Jieyu,Cheah, Yong Shung,Santhanakrishnan, Sridhar,Neoh, Koon Gee,Chai, Christina L.L.
, p. 5 - 15 (2017/03/31)
Deposition of polydopamine on substrates is a facile and effective method of surface modification and the deposited polydopamine can reduce silver ions to form silver nanoparticles (AgNPs) for antibacterial applications. However, polydopamine deposition is a time-consuming process that usually requires 24?h to produce a dense surface coating. Since oxidation of dopamine is critical for its polymerization, we hypothesize herein that substitution of an electron-donating group on the catechol ring of dopamine can enhance its oxidation potential and subsequently accelerate its polymerization. In this work, dopamine substituted with a 5-methoxy group (OMeDA) was prepared. OMeDA polymerized faster than dopamine under similar reaction conditions, resulting in a polymer coating of 13?nm thickness on a silicon surface after 8?h, compared to the 24?h required for dopamine to form a coating of similar thickness. A polymer layer with AgNPs can be directly formed on the silicon substrate after exposure to a solution containing OMeDA and silver nitrate. After 2?h exposure, the silver content on the modified surfaces prepared with OMeDA was 187% higher than that obtained with dopamine, and the antibacterial efficacy of the former against Staphylococcus aureus was correspondingly higher than that of the latter. This study demonstrates that OMeDA with an electron-donating group in the catechol ring offers improvements over dopamine for surface modification applications.
